Pharmacogenetics: Clinical Trials

4 trials for Pharmacogenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Unknown 2

Follow Pharmacogenetics: new trials by email Literature Review of Pharmacogenetics trials Research Report on Pharmacogenetics

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naproxen Pharmacogenetic Study (Project 1, Aim 2)
Naproxen tablet - Pharmacogenetics
Phase 4UnknownUniversity of Washington302016-01-122020-06-29
Pharmacogenomics Studies of Antidepressants
Venlafaxine, Fluoxetine - Major Depressive Disorder, Antidepressive Agents
Phase 4UnknownNational Cheng-Kung University Hospital2002007-03-012010-09-17
Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)
norepinephrine transporter polymorphism, - Attention Deficit Disorder With Hyperactivity, Methylphenidate
Phase 4CompletedHallym University Medical Center1502005-10-012011-10-05
A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension
Amlodipine, Bisoprolol, Hydrochlorothiazide - Hypertension, Pharmacogenetics
Phase 4CompletedHelsinki University Central Hospital2331999-11-252017-09-11

Narrower conditions

Attention Deficit Disorder with Hyperactivity (1)  ·  Depressive Disorder, Major (1)  ·  Hypertension (1)

Broader conditions

Mental Disorders (2)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Depressive Disorder (1)  ·  Mood Disorders (1)  ·  Neurodevelopmental Disorders (1)  ·  Vascular Diseases (1)

Interventions

Amlodipine (1)  ·  Bisoprolol (1)  ·  Fluoxetine (1)  ·  Hydrochlorothiazide (1)  ·  Losartan (1)  ·  Methylphenidate (1)  ·  Naproxen (1)  ·  Norepinephrine Plasma Membrane Transport Proteins (1)  ·  Polymorphism, Genetic (1)  ·  Time (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

Hallym University Medical Center (1)  ·  Helsinki University Central Hospital (1)  ·  National Cheng-Kung University Hospital (1)  ·  University of Washington (1)

Countries

Finland (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Kenneth E. Thummel, PhD (1)  ·  Kimmo K Kontula, Professor (1)  ·  Po See Chen, MD (1)

Results publications

PMID 17324745, PMID 18475165, PMID 25622599, PMID 29580174, PMID 35213289

NIH funding

P01GM116691 (1)